Rowatinex enteric capsules N50

Pinen

Capsules

Active ingredient: Pinen, camphene, tsineol, fenchone, borneol, anethol Concentration of active ingredient (mg): pinene [α + Β] - 31.0 mg, camphene - 15.0 mg, cineole - 3.0 mg, fenchon - 4, 0 mg, borneol - 10.0 mg, anethole - 4.0 mg

A herbal medicine that promotes disintegration and removal of kidney stones and urinary tract stones. Terpenes, such as borneol, undergo metabolic changes and are excreted in the urine, mainly in the form of glucuronides, which increases the solubility of calcium salts, which are the main components of kidney stones and urinary tract stones. In experimental studies, the inhibitory effect of Rowatinex on the formation of kidney stones and urinary tract stones was established. Rowatinex has an antispasmodic effect It promotes the passage of stones through the urinary tract, reduces pain during renal and ureteric colic, increases renal blood flow, improves kidney function and increases diuresis. The drug has an anti-inflammatory effect, antimicrobial effect (relative to a number of gram-positive and gram-negative microorganisms) colloids in the urine and increases the content of glucuronic acid in the urine.

Terpenes present in the preparation are fat-soluble and quickly absorbed. Terpenes, such as borneol, undergo significant metabolic changes in the human body, turning into glucuronides, which are excreted in the urine.

Urolithiasis (nephrolithiasis, urolithiasis). Prevention of kidney and urinary tract stones.

Hypersensitivity to the components of the drug, children under 6 years of age.

The drug should be stored out of the reach of children at a temperature not higher than 25 ° C.

It is not recommended to use Rowatinex in the first trimester of pregnancy and during lactation.

Is ingested before meals.

Hypersensitivity, stomach discomfort, vomiting.

Treatment: gastric lavage (if the drug is taken recently); patient monitoring should be established (monitoring of cardiac, respiratory, renal and hepatic functions); symptomatic therapy if necessary.

With the simultaneous use of Rowatinex can change the activity of anticoagulants, as well as drugs metabolized in the liver.

It is not recommended to apply Rowatinex in case of severe renal colic, anuria or severe urinary tract infection. Increase fluid intake during the treatment process.